Throughout 2020, clinicians around the world were focused on discovering the best patient care for COVID-19 by analyzing clinical data. In fact, the global response to COVID-19 underscored the importance of real-time, evidence-based decision-making.
At Q-Centrix, we’ve always considered clinical data to be among the most valuable resources available today. That’s why we’re dedicated to unlocking the total value of it for our partners. As part of our continued effort, we recently authored a new report on the state of the health care quality industry. However, due to the pandemic’s gravity, we had postponed its release—until now: State of the Industry: Health Care Quality Measurement Report.
The report, the third of its kind, fills key information gaps about quality measurement and resource needs for participating in performance improvement initiatives. A special report section summarizes key findings that include American health care consumers strongly value recognition for high-quality care.
In fact, a majority of survey respondents prioritized an excellence certification or other similar high-quality care designation over a referral from a physician, insurer, or family and friend when choosing where to go for treatment for a serious medical condition.
These findings are signs of the times—reflective of patients feeling more empowered to take control of their health.
The report also shares industry benchmarks related to resource commitments for clinical data programs. Insight into the data management needs for meaningful participation in key programs, such as clinical data registries, is scarce despite the fact these programs serve as a primary mechanism for earning quality and excellence distinctions.
Think about it this way: You do not want to make staffing decisions without reliable estimates of patient volumes. Similarly, you should not have to guess when you are allocating staff to clinical data management.
The report helps address this dilemma using a snapshot of the 14 most-commonly reported registry case types to estimate the full-time equivalent (FTE) commitment required. You will not find this type of data readily available from any other source.
Further, the report documents data registries’ increasing prominence across health care, including growing recognition by governments, private payers, and accrediting organizations for meeting key standards. For example, major insurers are using registry performance to determine which providers earn institutes of excellence or centers of distinction recognitions, which ultimately influence their patient members’ decisions about which providers to see.
Overall, the report provides a better understanding of quality programs to help health care leaders advance their performance strategies and improve patient care. Download the State of the Industry: Health Care Quality Measurement Report today at www.q-centrix.com.
Posted by Cathy Felts, Q-Centrix Vice President, Customer Experience